Literature DB >> 34072345

Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States.

Laura Bornes1, Guillaume Belthier1, Jacco van Rheenen1.   

Abstract

Epithelial-to-mesenchymal transition (EMT) is a cellular program which leads to cells losing epithelial features, including cell polarity, cell-cell adhesion and attachment to the basement membrane, while gaining mesenchymal characteristics, such as invasive properties and stemness. This program is involved in embryogenesis, wound healing and cancer progression. Over the years, the role of EMT in cancer progression has been heavily debated, and the requirement of this process in metastasis even has been disputed. In this review, we discuss previous discrepancies in the light of recent findings on EMT, plasticity and hybrid E/M states. Moreover, we highlight various tumor microenvironmental cues and cell intrinsic signaling pathways that induce and sustain EMT programs, plasticity and hybrid E/M states. Lastly, we discuss how recent findings on plasticity, especially on those that enable cells to switch between hybrid E/M states, have changed our understanding on the role of EMT in cancer metastasis, stemness and therapy resistance.

Entities:  

Keywords:  EMP; epithelia-to-mesenchymal transition (EMT); hybrid E/M states; plasticity; stemness; therapy resistance; tumor progression

Year:  2021        PMID: 34072345     DOI: 10.3390/jcm10112403

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  176 in total

1.  The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells.

Authors:  E Batlle; E Sancho; C Francí; D Domínguez; M Monfar; J Baulida; A García De Herreros
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

2.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

Authors:  Oscar H Ocaña; Rebeca Córcoles; Angels Fabra; Gema Moreno-Bueno; Hervé Acloque; Sonia Vega; Alejandro Barrallo-Gimeno; Amparo Cano; M Angela Nieto
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

3.  Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer.

Authors:  Nami Yamashita; Eriko Tokunaga; Makoto Iimori; Yuka Inoue; Kimihiro Tanaka; Hiroyuki Kitao; Hiroshi Saeki; Eiji Oki; Yoshihiko Maehara
Journal:  Clin Breast Cancer       Date:  2018-02-16       Impact factor: 3.225

4.  A causal role for E-cadherin in the transition from adenoma to carcinoma.

Authors:  A K Perl; P Wilgenbus; U Dahl; H Semb; G Christofori
Journal:  Nature       Date:  1998-03-12       Impact factor: 49.962

5.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

6.  Breast tumor cell-specific knockout of Twist1 inhibits cancer cell plasticity, dissemination, and lung metastasis in mice.

Authors:  Yixiang Xu; Dong-Kee Lee; Zhen Feng; Yan Xu; Wen Bu; Yi Li; Lan Liao; Jianming Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

7.  Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM.

Authors:  Kyung-A Song; Matthew J Niederst; Timothy L Lochmann; Aaron N Hata; Hidenori Kitai; Jungoh Ham; Konstantinos V Floros; Mark A Hicks; Haichuan Hu; Hillary E Mulvey; Yotam Drier; Daniel A R Heisey; Mark T Hughes; Neha U Patel; Elizabeth L Lockerman; Angel Garcia; Shawn Gillepsie; Hannah L Archibald; Maria Gomez-Caraballo; Tara J Nulton; Brad E Windle; Zofia Piotrowska; Sinem E Sahingur; Shirley M Taylor; Mikhail Dozmorov; Lecia V Sequist; Bradley Bernstein; Hiromichi Ebi; Jeffrey A Engelman; Anthony C Faber
Journal:  Clin Cancer Res       Date:  2017-10-19       Impact factor: 12.531

8.  Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis.

Authors:  Ievgenia Pastushenko; Federico Mauri; Yura Song; Florian de Cock; Bob Meeusen; Benjamin Swedlund; Francis Impens; Delphi Van Haver; Matthieu Opitz; Manuel Thery; Yacine Bareche; Gaelle Lapouge; Marjorie Vermeersch; Yves-Rémi Van Eycke; Cédric Balsat; Christine Decaestecker; Youri Sokolow; Sergio Hassid; Alicia Perez-Bustillo; Beatriz Agreda-Moreno; Luis Rios-Buceta; Pedro Jaen; Pedro Redondo; Ramon Sieira-Gil; Jose F Millan-Cayetano; Onofre Sanmatrtin; Nicky D'Haene; Virginie Moers; Milena Rozzi; Jeremy Blondeau; Sophie Lemaire; Samuel Scozzaro; Veerle Janssens; Magdalena De Troya; Christine Dubois; David Pérez-Morga; Isabelle Salmon; Christos Sotiriou; Francoise Helmbacher; Cédric Blanpain
Journal:  Nature       Date:  2020-12-16       Impact factor: 49.962

9.  Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway.

Authors:  Spencer C Wei; Laurent Fattet; Jeff H Tsai; Yurong Guo; Vincent H Pai; Hannah E Majeski; Albert C Chen; Robert L Sah; Susan S Taylor; Adam J Engler; Jing Yang
Journal:  Nat Cell Biol       Date:  2015-04-20       Impact factor: 28.824

10.  Metformin reveals a mitochondrial copper addiction of mesenchymal cancer cells.

Authors:  Sebastian Müller; Antoine Versini; Fabien Sindikubwabo; Guillaume Belthier; Supaporn Niyomchon; Julie Pannequin; Laurence Grimaud; Tatiana Cañeque; Raphaël Rodriguez
Journal:  PLoS One       Date:  2018-11-06       Impact factor: 3.240

View more
  8 in total

Review 1.  Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis.

Authors:  Mark Primeaux; Saiprasad Gowrikumar; Punita Dhawan
Journal:  Clin Exp Metastasis       Date:  2022-01-12       Impact factor: 5.150

Review 2.  The role of metabolic ecosystem in cancer progression - metabolic plasticity and mTOR hyperactivity in tumor tissues.

Authors:  Anna Sebestyén; Titanilla Dankó; Dániel Sztankovics; Dorottya Moldvai; Regina Raffay; Catherine Cervi; Ildikó Krencz; Viktória Zsiros; András Jeney; Gábor Petővári
Journal:  Cancer Metastasis Rev       Date:  2022-01-14       Impact factor: 9.264

3.  Epithelial-to-Mesenchymal Transition Drives Invasiveness of Breast Cancer Brain Metastases.

Authors:  Andreia S Margarido; Rebeca Uceda-Castro; Kerstin Hahn; Roebi de Bruijn; Lennart Kester; Ingrid Hofland; Jeroen Lohuis; Danielle Seinstra; Annegien Broeks; Jos Jonkers; Marike L D Broekman; Pieter Wesseling; Claire Vennin; Miguel Vizoso; Jacco van Rheenen
Journal:  Cancers (Basel)       Date:  2022-06-25       Impact factor: 6.575

Review 4.  Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence?

Authors:  Michal A Rahat
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

Review 5.  Regulation of epithelial-mesenchymal transition by protein lysine acetylation.

Authors:  Fanyun Kong; Lihong Ma; Xing Wang; Hongjuan You; Kuiyang Zheng; Renxian Tang
Journal:  Cell Commun Signal       Date:  2022-04-28       Impact factor: 7.525

Review 6.  Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies.

Authors:  Daniel L Pouliquen; Alice Boissard; Cécile Henry; Olivier Coqueret; Catherine Guette
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

Review 7.  Sirtuins and Hypoxia in EMT Control.

Authors:  Michele Aventaggiato; Federica Barreca; Luigi Sansone; Laura Pellegrini; Matteo A Russo; Marco Cordani; Marco Tafani
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-10

8.  Single-Cell RNA-seq Reveals a Developmental Hierarchy Super-Imposed Over Subclonal Evolution in the Cellular Ecosystem of Prostate Cancer.

Authors:  Guangzhe Ge; Yang Han; Jianye Zhang; Xinxin Li; Xiaodan Liu; Yanqing Gong; Zhentao Lei; Jie Wang; Weijie Zhu; Yangyang Xu; Yiji Peng; Jianhua Deng; Bao Zhang; Xuesong Li; Liqun Zhou; Huiying He; Weimin Ci
Journal:  Adv Sci (Weinh)       Date:  2022-03-24       Impact factor: 17.521

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.